Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Activating Patients to Engage Their Providers for Treatment of Hypertension: The VA Project to Implement Diuretics (VAPID)

Kaboli PJ, Ishani A, Holman JE, Vander Weg MW, Carter BL, Christensen AJ. Activating Patients to Engage Their Providers for Treatment of Hypertension: The VA Project to Implement Diuretics (VAPID). Poster session presented at: VA HSR&D National Meeting; 2009 Feb 14; Baltimore, MD.

Related HSR&D Project(s)




Abstract:

Objectives: Evidence-based guidelines recommend thiazide diuretics as first-line therapy for uncomplicated hypertension; however, thiazides remain under-utilized. The objective of our study was to test the efficacy of a patient-oriented intervention to initiate thiazides. Methods: 383 eligible hypertensive patients from 12 VA clinics not taking a thiazide and either previously not at blood pressure (BP) goal (uncontrolled HTN) or at goal and taking a calcium channel blocker (controlled CCB), which is not first-line therapy, were enrolled. Patients were randomized to a control group or three intervention groups designed to activate patients to talk to their providers about thiazides: Group A received an activation letter, Group B the letter with financial incentives, and Group C the letter, financial incentives, and reminder phone call. Outcomes were: 1) patient-initiated hypertension discussion and 2) thiazide prescribing. Results: Overall, the intervention resulted in Group A, B, and C discussion rates of 51%, 54%, and 71% (P < .001) with thiazide prescribing rates of 23%, 25%, and 32% (P < .001). In the uncontrolled HTN sub-group (N = 184), Group A, B, and C discussion rates were 47%, 48%, and 75% (P < .001) with thiazide prescribing rates of 31%, 25%, and 32% (P < .01). In the controlled CCB sub-group (N = 69), Group A, B, and C discussion rates were 57%, 74%, and 59% (P < .01) with thiazide prescribing rates of 7%, 26%, and 32% (P < .01). The control group (N = 130) thiazide prescription rate was 2.6%; all groups were significantly different from controls (P < 0.01). Patients not at BP goal were more likely to initiate thiazides than those at goal (OR 5.2, 95%CI 3.0-9.0). Of note, 51% of uncontrolled HTN patients had controlled BP at their clinic visit without change in their hypertension treatment. Implications: Providing patient-oriented information about thiazides for hypertension resulted in half of patients initiating discussions and one-fourth starting or switching to a thiazide, with a greater effect in uncontrolled patients than controlled patients. Adding a financial incentive and reminder phone call to the letter resulted in modest, but inconsistent, increases in both outcomes. Impacts: This low-cost, low-intensity, patient-activation intervention resulted in high rates of patient-initiated discussions and thiazide treatment. Future studies should investigate patient-activation to promote other areas of evidence-based medicine.





Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.